Trial Profile

Impact of Progesterone Substitution in Luteal Phase on Resting Energy Expenditure in Women During Menopausal Transition

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 19 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Progesterone (Primary)
Indications Menopausal syndrome; Menstruation disorders; Weight gain
Focus Pharmacodynamics
Acronyms P4&REE

Most Recent Events

15 Mar 2022 Status changed from recruiting to discontinued. Reason the study was stopped: massive recruitment problems became apparent because of the strict inclusion criteria of study.
21 Dec 2020 Planned End Date changed from 31 Aug 2021 to 31 Dec 2022.
21 Dec 2020 Planned primary completion date changed from 31 Mar 2021 to 31 Dec 2022.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com